 Financing to advance the scientific development of innovative COVID-19 nanobody treatments focused on protecting high-risk immunocompromised individuals Company developing highly potent antibodies ... Read Full Story at source may require registration The post ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank appeared first on ForexTV... 